INTRODUCTION
Nitric oxide (NO) is a gaseous signalling molecule that regulates several physiological processes that are important to exercise performance, including vasodilation, mitochondrial respiration and skeletal muscle contractility (Stamler and Meissner, 2001; Umbrello et al. 2013) . NO can be generated through the nitric oxide synthase (NOS)-catalysed oxidation of L-arginine and through the O 2 -independent, one-electron reduction of nitrite (NO 2 -). The reduction of NO 2 -to NO is enhanced in hypoxia and acidosis van Faassen et al. 2009 ) and, since contracting skeletal muscles become increasingly hypoxic and acidic during exercise, NOS activity may be reduced and NO 2 -reduction may become an increasingly important source of NO during exercise (Lundberg and Weitzberg 2010) .
Increasing plasma via NO 3 -supplementation has been reported to improve muscle oxygenation (Bailey et al. 2009; Masschelein et al. 2012) , muscle metabolic efficiency (Bailey et al. 2010; Larsen et al. 2011; Fulford et al. 2013 ) and contractile function (Hernandez et al, 2012; Haider and Folland et al. 2014; Coggan et al. 2015) , and to improve endurance exercise capacity at least in participants that are not highly trained (Bailey et al. 2009; Lansley et al. 2011; Cermak et al. 2012 ).
Recent evidence suggests that NO 3 -supplementation has the potential to preferentially enhance physiological responses in type II (fast-twitch), compared to type I (slow-twitch), skeletal muscle (Jones, 2014a) . Indeed, increased calcium handling proteins and contractile force has been observed in type II, but not type I, mouse skeletal muscle after NO 3 -supplementation (Hernandez et al. 2012 ). In addition, NO 3 -supplementation increased hind limb blood flow during exercise in rats, with this additional bulk blood flow being selectively directed towards type II muscle fibres (Ferguson et al. 2013) . Human studies suggest that NO 3 -supplementation can increase evoked explosive force production (Haider and Folland. 2014 ) and maximal voluntary power production (Coggan et al. 2015) in the knee extensors, 4 and can increase maximal sprint cycling power output (Rimer et al. 2015) and 180 m sprint running performance (Sandbakk et al., 2015) . However, while these findings suggest that NO 3 -supplementation has the potential to improve sprinting performance, the effects of NO 3 -supplementation on sprint running performance over short distances that reflect those exhibited during team sports match-play (10-20 m; Spencer et al. 2004; ) have yet to be investigated.
The activity pattern during team sports, such as football, rugby and hockey, is characterised by short-duration bouts of high-intensity exercise interspersed with brief recovery periods (Spencer et al. 2004) . Since this pattern of high-intensity intermittent exercise is associated with significant type II muscle recruitment (Krustrup et al. 2006 ) and, since NO 3 -supplementation can enhance physiological processes in type II muscle (Hernandez et al. 2012; Ferguson et al. 2013) , NO 3 -supplementation has the potential to enhance team-sportspecific high-intensity intermittent exercise performance. Consuming a very large NO 3 -dose (29 mmol) over 36 hours prior to exercise was shown to improve performance during the YoYo intermittent recovery level 1 test (Yo-Yo IR1; Wylie et al. 2013a ), a well-established and ecologically valid test widely used to mimic the high-intensity running bouts of football match-play (Bangsbo et al. 2008) . Performance can also be improved in short-duration intermittent cycling sprints after supplementation with a large NO 3 -dose (~8-13 mmol NO 3 -per day, over 3-7 days; Thompson et al. 2015; Wylie et al. 2016 ), but not with acute consumption of a small NO 3 -dose (~5 mmol NO 3 -per day; Martin et al., 2014) . However, the effects of short-term supplementation with a moderate NO 3 -dose on performance during a team-sport-specific intermittent performance test (i.e., a supplementation procedure that has been shown to be effective at improving continuous endurance exercise performance (Bailey et al. 2009; Lansley et al. 2011; Vanhatalo et al. 2010) ), remains to be determined.
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The ability to make quick and accurate decisions whilst simultaneously performing highintensity running exercise is a key determinant of team sport performance. It has been reported that acute low dose (~5 mmol) NO 3 -ingestion can increase resting brain blood flow and improve resting cognitive performance (Wightman et al. 2015) , and that NO 3 -supplementation (12.8 mmol NO 3 -per day for 7 days) can improve reaction time to cognitive tasks during prolonged intermittent sprint-cycling . However, the effect of NO 3 -supplementation on cognitive performance during an exercise test that simulates the movement patterns of team sport match-play has not been investigated.
The purpose of this study was to assess the effects of NO 3 -supplementation on team-sportspecific exercise performance variables and cognitive function before, during and after a YoYo IR1 test. We hypothesised that, compared to a placebo supplement, NO 3 -supplementation would: 1) improve sprint running performance; and 2) improve exercise and cognitive performance during a Yo-Yo IR1 test.
METHODS

Subjects
Thirty-six male team-sport players from local football, rugby and hockey teams (mean ± SD: age 24 ± 4 years, height 1.80 ± 0.07 m, body mass 80 ± 10 kg) volunteered to participate. The subjects trained (5-10 hours per week) and participated regularly in university and local league competitions. None of the subjects were supplementing their diet with any putative ergogenic aid for 6 months prior to the start of the study. Following an explanation of the experimental procedures, associated risks, potential benefits and likely value of possible findings, subjects gave their written informed consent to participate. Experimental visits were scheduled at the same time of day (± 2 h). Subjects were instructed to record their diet during the 24 h preceding the first experimental visit and to repeat this prior to the second visit. They were not specifically asked to refrain from the consumption of high-NO 3 -foods. Subjects were also instructed to arrive at the laboratory ≥3 h post-prandial, having avoided strenuous exercise and the consumption of alcohol in the 24 h preceding, and caffeine in the 8 h preceding, each experimental visit. For the duration of the study, subjects were asked to refrain from taking other dietary supplements, and also to avoid using antibacterial mouthwash as this inhibits the reduction of NO 3 -to NO 2 -in the oral cavity by eliminating commensal bacteria (Govoni et al. 2008) .
Supplementation
Following the initial screening and familiarization visit, subjects were allocated to receive using a modified chemiluminescence technique as previously described (Wylie et al. 2013b ).
Then, following 10 min seated rest in a quiet room, three measurements of blood pressure were recorded using an automated sphygmomanometer (Dinamap Pro: GE Medical Systems, Tampa, FL).
Cognitive assessment
Subjects were asked to complete a Stroop test before, at 75% maximal distance and immediately following the Yo-Yo IR1 test. The Stroop test was delivered using E-Prime® 2.0 (Psychology Software Tools, Inc. 2013) and presented on a laptop screen positioned at the finish line marker of the Yo-Yo IR1 test. Subjects were instructed to respond as quickly and as accurately as possible to a series of text stings, as previously described , using a custom-made keyboard with response reaction time and accuracy recorded. accuracy to the Stroop tests before, during and after YoIR1 were analyzed using two-way, repeated-measures ANOVAs (supplement × time). Significant main and interaction effects were followed up with Fisher's LSD post hocs. Relationships between performance in PL and changes in performance following BR were analyzed using Pearson product moment correlation coefficients. All values are reported as mean ± SD. Statistical significance was accepted at P < 0.05.
RESULTS
The BR and PL treatments were well tolerated by the subjects and no adverse events were noted during the course of the study. The subjects reported that they complied fully with the supplementation protocol and with the instruction to record their diet during the 24 h preceding the first experimental visit and to replicate this prior to the second visit. There was no effect of testing order on sprint performance (P>0.05).
Yo-Yo IR1 performance
Compared to PL, the distance covered in the Yo-Yo IR1 test was 3.9% greater following BR supplementation (BR 1422 ± 502 vs. PL 1369 ± 505 m; P<0.05; Fig. 3 ). There was no effect of testing order on Yo-Yo IR1 test performance (P>0.05).
Cognitive performance
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The overall response time to the Stroop tasks was shorter in BR (612 ± 102 ms) compared to PL (628 ± 103 ms; P<0.05) corresponding to a 2.6% improvement in speed of reaction.
Specifically, the greatest improvement in reaction time between BR and PL was observed during the cognitive tests performed at rest (BR: 615 ± 98 ms vs PL: 645 ± 120; P<0.05).
There were no significant improvements in reaction time between BR and PL at the 75% 
The effect of BR on maximal sprint running performance
Although previous studies have reported improved maximal sprint cycling performance (Rimer et al. 2015; Thompson et al. 2015) and 180 m sprint running performance (Sandbakk et al. 2015) after NO 3 -supplementation, our study is the first to demonstrate that NO 3 -supplementation can improve performance during 5, 10 and 20 m sprint running by ~1-2%.
This finding is important since it suggests that NO 3 -supplementation can improve sprint performance within the exercise mode (i.e., running) and over the distances (5-20 m) that are typical of match-play in a wide range of team sports (Spencer et al. 2004; .
Given the differences that have been reported in explosive force (Haider and Folland. 2014) and maximal power of inertial-load cycling (Coggan et al. 2015) following NO 3 -supplementation, it might be anticipated that any ergogenic effect might be accentuated during the initial phase of all-out sprinting. Indeed, our findings indicate that the greatest improvement in sprint performance (2.3%) occurred over the initial 5 m. Moreover, BR continued to enhance speed between 5 m and 10 m. Together with previous observations of improved sprint performance (Rimer et al. 2015; Thompson et al. 2015; Sandbakk et al. 2015) , these findings strengthen the evidence base for using NO 3 -as a nutritional aid to enhance aspects of sprint running performance.
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The improved sprint performance after NO 3 -supplementation might be a function of the effects of NO 3 -supplementation on force production: 1) in type II muscle and 2) at high contraction velocities, since maximal sprinting requires both significant type II muscle recruitment and high contraction velocities (Greenhaff et al. 1994) . Specifically, NO 3 -supplementation has been shown to increase force production or performance: 1) during the initial stages of high-frequency contractions (Haider and Folland 2014) ; 2) at high, but not low, contraction velocities (Bailey et al. 2015; Coggan et al. 2015) ; and 3) in type II, but not type I, skeletal muscle in association with improved skeletal muscle calcium handling (Hernandez et al., 2012) . Therefore, our results are consistent with observations of improved contractile function in studies using isolated muscle models and extend these findings to suggest that NO 3 -supplementation can enhance maximal sprint running performance over distances typically completed by team sports athletes during competition.
The effect of BR on performance during the YoYo IR1 test
Several studies have investigated the effects of NO 3 -supplementation on high-intensity intermittent exercise performance but the results have been ambiguous, likely due to marked differences in test protocol and the dose and duration of NO 3 -supplementation (Aucouturier et al. 2015; Bond et al. 2012; Christensen et al. 2013; Martin et al. 2014; Muggeridge et al. 2013 ; Thompson et al. 2015; Wylie et al. 2013; 2016) . In the present study, we observed a 3.9% improvement in the Yo-Yo IR1 test, which mimics the high-intensity running bouts of football match-play (Bangsbo et al. 2008) , after short-term NO 3 -supplementation. This finding is consistent with our previous observation of improved Yo-Yo IR1 test performance (+4.2%) after consuming a large NO 3 -dose (29 mmol) over 36 hours prior to testing, and suggests that a similar performance gain can be achieved by ingesting a moderate NO 3 -dose (6.4 mmol NO 3 -per day) for 5 days.
14 Given that the reduction of NO 2 -to NO is potentiated with decreasing O 2 tension van Faassen et al. 2009 ) and that PO 2 is lower in type II compared to type I muscle (Behnke et al. 2003; McDonough et al. 2005 Thompson et al. 2015) . Moreover, the decline in plasma [NO 2 -] was correlated to the improvement in exercise performance observed in these studies (Wylie et al. 2013a; Thompson et al. 2015) . Given that circulating NO 2 -is an important correlate of exercise performance both in healthy, recreationally-active subjects (Dreissigacker et al. 2010; Rassaf et al., 2007) and in trained subjects (Lansley et al. 2011; Wilkerson et al. 2012) , the greater Yo-Yo IR1 performance in BR may be attributable to enhanced generation of NO 2 --derived NO during exercise.
NO 3 -ingestion has been shown to reduce the adenosine triphosphate (ATP) and phosphocreatine (PCr) cost of muscle force production during high-intensity continuous (Bailey et al. 2010 ) and intermittent (Fulford et al. 2013) exercise. Furthermore, NO 3 -supplementation has been reported to attenuate the slowing of PCr recovery observed in hypoxia, restoring PCr recovery kinetics following exercise to values observed in normoxia (Vanhatalo et al. 2011; . It is known that, with increasing exercise intensity, a greater recruitment of type II fibres (Sale et al. 1987; Copp et al. 2010 ) and a slower rate of resynthesis of ATP and PCr in type II fibres between high intensity bouts occurs (Casey et al. 1996) . Therefore, the effects of NO 3 -supplementation on muscle PCr utilisation during highintensity exercise (Bailey et al. 2010; Fulford et al. 2013 ) and on the rate of muscle PCr resynthesis following exercise (Vanhatalo et al. 2011; may be important determinants of the improved high-intensity intermittent exercise performance reported herein.
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In combination, the improved 5, 10 and 20 m maximal sprint running performance and the improved Yo-Yo IR1 performance suggest that short-term NO 3 -supplementation can improve several physical determinants of success in team sports and support the use of NO 3 -supplementation as an ergogenic aid for team sports competitors. There were weak negative correlations between sprint performance in the PL condition and the magnitude of the improvement in sprint performance with BR supplementation (r = -0.35-0.39), indicating that the subjects with the poorest sprint performance benefited more from BR supplementation.
This observation would be consistent with reports that NO 3 -supplementation is generally less effective in enhancing endurance performance in athletes with high levels of aerobic fitness (Wilkerson et al. 2012; Jones, 2014b; Porcelli et al. 2015) although some 20% of elite athletes may still respond positively (Christensen et al. 2013; Boorsma et al. 2014 ). Further research is therefore required to determine whether the findings of the present study of recreational team sport players can be reproduced in highly-trained team sports athletes and/or whether a 'targeted' approach to individuals with relatively poor sprint performance might be recommended.
The effect of BR on cognitive performance during the YoYo IR1 test
There was no change in cognitive function, as inferred from response reaction time and accuracy during the Stroop test, during or following the Yo-Yo IR1 test. This finding conflicts with our previous observation of improved Stroop test performance (faster response reaction time for the same response accuracy) during a prolonged intermittent sprint-cycling protocol after NO 3 -supplementation . These conflicting findings might be linked to the higher NO 3 -dose used in our previous study (12.8 mmol NO 3 -per day for 7 days, Thompson et al. 2015) compared to the current study (6.4 mmol NO 3 -per day for 5 days). Alternatively, or in addition to different NO 3 -dosing procedures, these inter-study differences in Stroop test performance might be related to the completion of numerous cognitive tests throughout the more lengthy exercise protocol used previously, thus increasing test sensitivity , compared to the single 90 s Stroop test completed during a seated rest within the Yo-Yo IR1 test in the present study. Moreover, cognitive test performance typically becomes more variable in a fatigued state, rendering it more difficult to ascertain differences in performance between conditions.
The effect of BR on cognitive performance at rest
In contrast to results during exercise, NO 3 -supplementation improved decision-making reaction time to the Stroop tasks performed during the resting baseline period. This observation is consistent with Wightman et al. (2015) who reported improved cognitive function at rest in the serial 3s subtraction task following an acute dose of dietary NO 3 -. This was associated with improved cerebral blood flow in the prefrontal cortex at the onset of the task period. Similar to the serial 3s subtraction task, the Stroop task assesses the capacity for information processing (Besner and Roberts 2005) and performance in these tasks is related to the functioning of the prefrontal cortex. NO is pivotal to a number of cerebral processes including neurotransmission, vasodilation and neurovascular coupling (Aamand et al. 2013; Iadecola et al. 1999; Piknova et al. 2011; Rifkind et al. 2007 ). Dietary NO 3 -has been shown to improve regional brain perfusion (Presley et al. 2011) , attenuate cerebral O 2 extraction during mental processing (Thompson et al. 2014) , and enhance coupling of cerebral blood flow to neuronal activity (Aamand et al. 2013) . Therefore, the modulation of cerebral haemodynamics, especially in response to cognitive task performance (Wightman et al. 2015) , may underpin the differences in response time between BR and PL in the present study. However, it is somewhat surprising that the greatest improvement in cognitive function was observed at rest and not during exercise when the difference between conditions in cerebral oxygenation is expected to be more pronounced and the potential for NO generation from NO 2 -reduction is expected to be increased van Faassen et al. 2009 ). Further studies are required to investigate the effects of NO 3 -supplementation on cerebral oxygenation and cognitive function during high-intensity intermittent exercise.
Experimental Considerations
It is important to recognize that the efficacy of putative ergogenic aids in sport is related to a host of variables including subject characteristics (sex, age, training status), exercise modality and protocol (duration, intensity, continuous or intermittent), and dosing strategy (quantity, acute or chronic intake). In this respect, our study indicates that BR supplementation improves sprint and intermittent high-intensity exercise performance under the particular conditions of our investigation, namely in competitive but sub-elite team sport players consuming a moderate dose of NO 3 -for 5 days. Further clearly-defined and well-executed research studies are needed to test the various possible permutations (amongst subject type, exercise protocol, and dosing regimen) to better delineate the other circumstances in which BR or NO 3 -supplementation may, or may not be effective. A key strength of the present investigation was the recruitment of a large sample size and the employment of validated protocols to which the subjects were familiarized prior to commencement of the study. When differences between conditions are relatively small (i.e., 1-2% for sprint performance), albeit but they are highly meaningful to sports performance outcomes (Hopkins et al. 1999) , it is clearly important that studies are sufficiently powered to ensure that false conclusions are not drawn with regard to supplement efficacy. A limitation to our study was that we were unable to control subjects' diet but relied instead on the subjects recording their food consumption in the 24 h prior to the first experimental visit and replicating this prior to the second experimental visit . While the subjects reported that they had complied with this requirement, future studies might control pre-test diet more rigorously. It should also be noted that our study design (daily supplement intake for 4 days plus a final supplement intake 2.5 h before 18 the exercise tests) does not allow us to differentiate between the effects elicited by chronic vs acute BR ingestion.
In conclusion, this study has made an important contribution to our understanding of the ergogenic potential of dietary NO 3 -supplementation for sprint and team sports athletes.
Specifically, our results indicate that short-term supplementation (5 days) with a moderate 
